Stallergenes, seeking an edge in a competitive space, taps Aptar for connected drug delivery project ntaylor Mon, 11/01/2021 – 12:23 More: Stallergenes, seeking an edge in a competitive space, taps Aptar for connected drug delivery project Source: fierce
read moreAbbVie’s Parkinson’s pump hits goal in phase 3, setting stage for approval filings ntaylor Mon, 11/01/2021 – 12:20 More: AbbVie’s Parkinson’s pump hits goal in phase 3, setting stage for approval filings Source: fierce
read moreAstraZeneca resumes asset sale in $270M COPD deal with familiar buyer Covis aliu Mon, 11/01/2021 – 11:19 More: AstraZeneca resumes asset sale in 0M COPD deal with familiar buyer Covis Source: fierce
read moreJaguar to pump $125M into North Carolina gene therapy manufacturing facility jkeenan Mon, 11/01/2021 – 10:20 More: Jaguar to pump 5M into North Carolina gene therapy manufacturing facility Source: fierce
read moreAmid a push to resolve opioid and talc claims, Johnson & Johnson settles Risperdal litigation for $800M kdunleavy Mon, 11/01/2021 – 10:08 More: Amid a push to resolve opioid and talc claims, Johnson & Johnson settles Risperdal litigation for 0M
read moreAstraZeneca has announced it will transfer global rights to respiratory meds Eklira and Duaklir to Covis Pharma More: AZ to transfer certain drug rights to Covis Pharma for 0m Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals